Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16928832

Download in:

View as

General Info

PMID
16928832